vs
爱尔康（ALC）与Brightstar Lottery PLC（BRSL）财务数据对比。点击上方公司名可切换其他公司
爱尔康的季度营收约是Brightstar Lottery PLC的1.0倍（$2.6B vs $2.5B），爱尔康净利率更高（6.8% vs 5.9%，领先0.9%）
爱尔康是瑞美合资的制药及医疗器械企业，专注于眼健康护理产品领域。公司注册地为瑞士弗里堡州，全球总部设于日内瓦，核心运营基地位于美国得克萨斯州沃思堡，当地员工规模约4500人。
ALC vs BRSL — 直观对比
营收规模更大
ALC
是对方的1.0倍
$2.5B
净利率更高
ALC
高出0.9%
5.9%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.6B | $2.5B |
| 净利润 | $176.0M | $147.0M |
| 毛利率 | 53.5% | — |
| 营业利润率 | 9.5% | 11.9% |
| 净利率 | 6.8% | 5.9% |
| 营收同比 | 4.0% | — |
| 净利润同比 | -21.1% | — |
| 每股收益（稀释后） | $0.35 | $0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALCBRSL
| Q4 25 | — | $2.5B | ||
| Q2 25 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q4 23 | — | $2.5B | ||
| Q2 23 | $2.4B | — | ||
| Q4 22 | — | $2.6B | ||
| Q2 22 | $2.2B | — |
净利润ALCBRSL
| Q4 25 | — | $147.0M | ||
| Q2 25 | $176.0M | — | ||
| Q2 24 | $223.0M | — | ||
| Q4 23 | — | $156.0M | ||
| Q2 23 | $169.0M | — | ||
| Q4 22 | — | $275.0M | ||
| Q2 22 | $148.0M | — |
毛利率ALCBRSL
| Q4 25 | — | — | ||
| Q2 25 | 53.5% | — | ||
| Q2 24 | 55.0% | — | ||
| Q4 23 | — | — | ||
| Q2 23 | 56.3% | — | ||
| Q4 22 | — | — | ||
| Q2 22 | 54.3% | — |
营业利润率ALCBRSL
| Q4 25 | — | 11.9% | ||
| Q2 25 | 9.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q4 23 | — | 29.7% | ||
| Q2 23 | 11.1% | — | ||
| Q4 22 | — | 28.6% | ||
| Q2 22 | 9.0% | — |
净利率ALCBRSL
| Q4 25 | — | 5.9% | ||
| Q2 25 | 6.8% | — | ||
| Q2 24 | 8.9% | — | ||
| Q4 23 | — | 6.2% | ||
| Q2 23 | 7.0% | — | ||
| Q4 22 | — | 10.6% | ||
| Q2 22 | 6.7% | — |
每股收益（稀释后）ALCBRSL
| Q4 25 | — | $0.74 | ||
| Q2 25 | $0.35 | — | ||
| Q2 24 | $0.45 | — | ||
| Q4 23 | — | $0.77 | ||
| Q2 23 | $0.34 | — | ||
| Q4 22 | — | $1.35 | ||
| Q2 22 | $0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $1.4B |
| 总债务越低越好 | — | $4.1B |
| 股东权益账面价值 | $22.1B | $875.0M |
| 总资产 | $31.4B | $9.2B |
| 负债/权益比越低杠杆越低 | — | 4.64× |
8季度趋势，按日历期对齐
现金及短期投资ALCBRSL
| Q4 25 | — | $1.4B | ||
| Q2 25 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q4 23 | — | $508.0M | ||
| Q2 23 | $661.0M | — | ||
| Q4 22 | — | $590.0M | ||
| Q2 22 | $1.0B | — |
总债务ALCBRSL
| Q4 25 | — | $4.1B | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $5.7B | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $5.7B | ||
| Q2 22 | — | — |
股东权益ALCBRSL
| Q4 25 | — | $875.0M | ||
| Q2 25 | $22.1B | — | ||
| Q2 24 | $20.9B | — | ||
| Q4 23 | — | $1.4B | ||
| Q2 23 | $19.9B | — | ||
| Q4 22 | — | $1.4B | ||
| Q2 22 | $19.5B | — |
总资产ALCBRSL
| Q4 25 | — | $9.2B | ||
| Q2 25 | $31.4B | — | ||
| Q2 24 | $29.7B | — | ||
| Q4 23 | — | $10.5B | ||
| Q2 23 | $29.2B | — | ||
| Q4 22 | — | $10.4B | ||
| Q2 22 | $27.7B | — |
负债/权益比ALCBRSL
| Q4 25 | — | 4.64× | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 3.92× | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 3.98× | ||
| Q2 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-415.0M |
| 自由现金流率自由现金流/营收 | — | -16.5% |
| 资本支出强度资本支出/营收 | — | 12.6% |
| 现金转化率经营现金流/净利润 | — | -0.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALCBRSL
| Q4 25 | — | $-99.0M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $1.0B | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $899.0M | ||
| Q2 22 | — | — |
自由现金流ALCBRSL
| Q4 25 | — | $-415.0M | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $865.0M | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $737.0M | ||
| Q2 22 | — | — |
自由现金流率ALCBRSL
| Q4 25 | — | -16.5% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 34.2% | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 28.4% | ||
| Q2 22 | — | — |
资本支出强度ALCBRSL
| Q4 25 | — | 12.6% | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 5.8% | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 6.2% | ||
| Q2 22 | — | — |
现金转化率ALCBRSL
| Q4 25 | — | -0.67× | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 6.49× | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 3.27× | ||
| Q2 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
